Search for Clinical Trial Results
Pustular Psoriasis - 29 Studies Found
Status | Study |
Completed |
Study Name: Study to Assess the Efficacy, Safety and Tolerability of Secukinumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP) Condition: Psoriasis Date: 2013-09-24 Interventions: Biological: Secukinumab Secukinumab 150 mg, provided in a 1 mL prefilled syringe (one syringe for 150 mg |
Recruiting |
Study Name: BI655130 Single Dose in Generalized Pustular Psoriasis Condition: Psoriasis Date: 2016-11-29 Interventions: Drug: BI655130 |
Recruiting |
Study Name: A Study to Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic Psoriasis Condition:
|
Completed |
Study Name: An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis Condition: Psoriasis Date: 2013-01-27 Interventions: Drug: KHK4827 140 mg (dosage may be increased to 210 mg in case of insufficient efficacy) |
Completed |
Study Name: A Phase 3 Clinical Study of KHK 4827 Condition:
|
Completed |
Study Name: A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis Condition:
|
Completed |
Study Name: Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar Pustulosis Condition:
|
Recruiting |
Study Name: Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases Condition:
|
COMPLETED |
Study Name: HB0034 in Patients With Generalized Pustular Psoriasis (GPP) Condition: Generalized Pustular Psoriasis Date: 2024-05-19 Interventions: HB0034, a single dose |